Everyone online is suddenly injecting peptides. But almost nobody understands the scienceor the regulation., The FDA recently shifted several peptides off the Category 2 safety risk list tied to FDA to weigh easing limits on unproven peptides favored by RFK Jr. FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with